Rhizoctonia muneratii ATCC 13247 was capable of catalyzing the conversion of 25-hydroxycholesterol to the 3-oxo-4-ene. Hydroxylation at the 6a and 6p positions with the concomitant 3-oxo-4-ene transformation was also observed. The addition of Triton X-100 to the growth medium immediately before steroid addition selectively prevented the appearance of the respective 6a-hydroxylated products. The observed conversions were indicative of the utility of microbial transformations in preparing hydroxylated steroids which can be useful for further synthetic modification or for study as pharmacological agents.
The utility of microorganisms in accomplishing difficult stereospecific modifications of chemicals has been well documented in the literature (5, 6) . Selective hydroxylations, oxidations, reductions, etc., have been especially exploited to alter the functionality present on a steroid ring system or side chain, often to produce in an efficient biological sequence a transformation which, chemically, would require many synthetic reactions. For example, the routes of microbial metabolism of cholesterol have been investigated (1, 10, 11) . It has been shown that degradation of the side chain and the ring system usually occurs readily (1, 11, 15) . However, these degradation processes have been refined to produce industrially useful compounds (5, 6) such as androstadienes and cortisols, and many patents may be found for these processes.
In a study under way at our laboratory the ability of the fungus Rhizoctonia muneratii to transform 25-hydroxycholesterol (5-cholesten-3,25-diol), abbreviated as HC25, has been investigated. This compound is commercially useful (12) as an intermediate in the multistep chemical synthesis of active hormonal forms of vitamin D3 (cholecalciferol). Because of the hydroxy group at C-25, the side chain of HC25 should not undergo degradation as readily as cholesterol, and it was postulated that microbial transformation of the HC25 might yield metabolites previously unobserved for this particular compound. However, HC25 is a compound quite unlike cholesterol due to the polarity, solubility, and other differences conferred by the presence of tPresent address: Energy Resources Co., Inc., Cambridge, MA 02139. the 25-OH group. Unlike cholesterol, HC25 is not a naturally occurring substance, but is a synthetic intermediate of chemical manufacture. Moreover, the administration of HC25 to some mammalian systems has been shown to result in significant interference with normal sterol synthesis, DNA synthesis, and membrane composition (8, 9) . It was our hope that some microbial conversion product of HC25 might be obtained for use as an intermediate for further synthetic modification. The purpose of this report is to describe the efficacy of R. muneratii in transforming HC25 to hydroxylated and further derivatized products.
MATERIALS AND METHODS Microbial procedures. The culture was obtained from the American Type Culture Collection (ATCC), Rockville, Md., as an agar slant designated R. muneratii 13247. The following formulation for the agar medium was supplied by the ATCC (medium 336): extract of 300 g of diced potatoes in 500 ml of water, boiled and filtered through cheesecloth; 20 g of glucose; 5 g of yeast extract (Difco Laboratories); 15 g of agar; and water to 1 liter. The medium was prepared in bulk and transferred aseptically to other containers as needed.
Suspensions of mycelia in sterile water were then transferred to the agar, and the cultures were allowed to grow at 26°C for 4 to 7 days or until new cultures were well established. The slants or plates were then refrigerated at 5°C; slants were subcultured once every 3 months, and plates were transferred biweekly.
Fungi maintained on solid medium (plates) were utilized as starter inocula for liquid culture. The agar blocks containing the established mycelia were aseptically removed from the plates and were placed in a sterile Waring blender; sterile liquid CSY broth (G. Greenspan and C. P. Schaffner, U.S. patent 2,968,595, 17 January 1961) was added, and the cultures were thoroughly macerated and agitated for 1 to 2 min. This suspension was then distributed into sterile Erlenmey-er flasks containing CSY medium at a ratio of the contents of one plate to 300 to 350 ml of broth. These intermediate flasks were then incubated at 26°C for 7 days on a gyratory shaker at 200 rpm and were monitored daily for pH and glucose consumption. For the glucose measurements, a Statzyme glucose quantitative analysis kit (Worthington Diagnostics, Freehold, N.J.) was used with appropriate blanks and standards. This was a coupled enzymatic analytical method specific for glucose, in which glucose is first oxidized by glucose oxidase, producing D-glucono-&-lactone and hydrogen peroxide. The hydrogen peroxide thus formed is coupled by peroxidase with a chromogen to yield a chromophore with an absorbance maximum at 500 nm. The change in absorbance at 500 nm is directly proportional to the glucose concentration in the sample, and use of this chromophoric method eliminated the need for a measurement in the UV range. Additional details concerning this assay may be obtained from the manufacturer. This parameter was chosen for measurement of the course of the fermentation since the cultures in the flasks were typically turbid and difficult to measure by other means, such as light scattering, etc.
The resultant cultures were homogenized in a sterilized Waring blender for 30 s and then diluted with sterile water in a ratio of 100 ml of water to about 1,400 ml of cells. Samples were then added to freshly prepared CSY broth in a ratio of 300 ml of new medium to 150 ml of cell suspension. The cultures were allowed to grow at 26°C at 200 rpm for 48 h.
The steroids were added routinely as appropriate volumes of ethanolic stock solution (12.5 mg of steroid per ml of ethanol) to a final concentration of 0.5 g/liter of culture. In certain experiments steroid addition was preceded by the aseptic addition of Triton X-100 to a final concentration of 0.1%. Thereafter, samples of cultures were removed at the appropriate times and reserved for subsequent assay and product recovery.
During the experiments 10-ml samples of broth were removed every 24 h before steroid addition. Immediately after steroid addition another sample was removed, and similar samplings were taken simultaneously with samples removed for CHCl3 extraction, to be used for the glucose measurement.
Control experiments. Appropriate control and experimental flasks were prepared by similar procedures, except that control flasks were autoclaved at 48 h after inoculation (two cycles at 121°C for 30 min) and just before steroid addition, to ensure that no nonenzymatic transformation products would be reported. Control flasks were also prepared by not adding the test steroid to viable cultures. Control and experimental flasks were incubated, extracted, and analyzed by similar procedures.
Sample extraction. Samples (50 ml) were extracted with three 50-ml volumes of chloroform in the initial screening experiments. When larger volumes of steroid-containing broth were required to recover greater quantities of product, the broths were extracted with three times the volume of sample removed, utilizing chloroform in all cases. The chloroform extracts were then evaporated under vacuum to a volume of 5 ml for assay.
Instrumentation. All mass spectra were obtained by using a solids inlet probe on a Hewlett-Packard (Palo Alto, CA.) 5930A gas chromatograph-mass spectrometer (MS)-computer system. The sample size was 1 ,ul of extracted products from the fermentation, and the sensitivity level was 5 ng.
Liquid chromatograms (LC) were obtained by injecting 10 ,ll of the fermentation extracts in a system using three Partisil PXS 25/5 columns fitted on a Hewlett-Packard model 1084A high-pressure liquid chromatograph (HPLC). The detector was a PerkinElmer (Norwalk, CT) LC-55 variable-wavelength UV spectrophotometer set at 216 nm. The solvents were hexane (A) and 20%o methanol in tetrahydrofuran (B).
The chromatographic conditions were usually 35% B in A and a solvent flow of 1.5 ml/min. To obtain baseline separation of the components for collection purposes the conditions were changed to 30%o B in A and a flow of 1.0 ml/min. The sensitivity level was generally 50 ng, but varied slightly depending on the extinction coefficient of the steroid. In some cases a 79877A refractive index detector was also used. The structures of the postfermentation steroid products were determined typically by proton and carbon nuclear magnetic resonance (NMR) with Bruker WP-80 and JEOL JMM F-100 spectrometers. Solution concentrations were generally 1 to 2 mg of sample in 100 p.1 of solvent. When possible, the metabolites were compared with authentic chemically prepared standards.
Infrared (IR) spectra were obtained by using a model 457 diffraction grating spectrophotometer (Perkin-Elmer), and all compounds were run in chloroform. UV spectra were measured on a Cary 219 spectrophotometer.
Criteria for steroid transformations. Several criteria were established for a successful steroid transformation for purposes of these experiments. Peterson and co-workers (13) have shown that steroid uptake by fungal cell preparations is dependent on the presence of a usable energy source; thus, one requisite for the transformation became the demonstration of glucose utilization at a consistent rate during the fermentatidn experiments, which was 4.0 x 1074 mol of glucose per liter per h for this strain.
Similarly, other criteria pertaining to the chromatographic analysis were chosen. For confirmation of a conversion, the LC traces were judged as follows: (i) the areas of peaks corresponding to starting materials must decrease with time; (ii) the corresponding product peak areas must increase with time; (iii) the products must be present in greater than 1% of the total area produced by the LC peaks; (iv) the product must persist at greater than 1% in two consecutive samples. 
RESULTS
Transformation of HC25. Initial duplicate cultures, with or without added Triton X-100, were sampled every 4 h after steroid addition. R. muneratii was found to convert HC25 to more than one product. For example, shown in Fig. 1 are the LC traces of the extracts after 48 h of culture incubation time with HC25. By LC analysis of the Triton X-100-free preparation the first-eluting metabolite, compound 2, displayed a retention time of 7.88 min (Fig. 1A) , eluting before the starting material. After a peak which displayed a retention time (8.34 min) consistent with nontransformed HC25 (compound 1), two other peaks were observed, with retention times of 8.82 min (compound 3) and 9.59 min (compound 4). In the extract from the Triton X-100-containing flask, although the retention times of the products were virtually the same, compound 4 was not observed (Fig. 1B) . When the appearance of products was studied as a function of time, both extracts were found to contain similar patterns of accumulated metabolites, and the maximum accumulation of each product was found after 48 h of incubation (Fig. 2) . In this figure the concentration of each component has been expressed as a percentage of that component's maximum concentration. Hence, the maximum concentration attainable for a particular metabolite at a given time has been set or normalized to 1.0.
To determine the structures of the metabolites and in particular the identity of compound 4, a 1.2-liter culture was grown with Triton X-100 omitted to maximize the number of products. After 48 h of incubation with HC25 the culture was harvested and extracted as described above. The three peaks comprising product plus the unreacted HC25 (compound 1) were separated by successively injecting crude samples until the sample was exhausted and each peak was isolated. Figure 3 shows the elution pattern using a refractive index detector which allowed for a better approximation as to the relative amounts of each component present. The three components of the product mixture and nonconverted compound 1 were found to comprise the following percentages of the 48-h sample extract: unreacted compound 1, 35%; compound 2, 10%; compound 3, 49%; and compound 4, 6%. Essentially no breakdown products of compound 1 were observed at the time of extraction (48 h). The starting material and the three metabolites are shown in Fig. 4 . , and loss of a methyl group, mle = 369. A major absorption at 212 nm in the UV scan plus peaks at 3.38 and 3.46 ,um in the IR spectrum indicated that these peaks were also present in the compound 1 reference spectra. Hence, the peak eluting at 8.34 min was assigned as compound 1, unreacted HC25.
(ii) Compound 2. Mass determination of compound 2 gave a molecular weight of 400, discerned from a distinctive cluster of ions at mle 382 to 385, inclusive. The mle 382 was due to the loss of water from the parent ion; mle 385 was due to the cleavage of a methyl group. The cluster further revealed that the steroid nucleus was intact and contained one hydroxyl group.
If both hydroxyl groups on compound 1 had remained intact, a pattern of ions similar to that of mle 382 to 385 would be expected to occur also around ions 364 to 367. This would be due to the loss of a second molecule of water from the steroid structure. This was not the case, and therefore, the increase in unsaturation found from M+ = 400 was assigned to one of the hydroxyl groups as an oxidation of a hydroxyl group to a ketone. Therefore, the structure of compound 2 differed from compound 1 in that one of the hydroxyl groups had been converted to a ketone.
The proton NMR spectrum of compound 2 (Table 1 ) displayed a vinyl signal at 85.71 consistent with the 4-ene-3-one oxidation isomerization of the AB ring (2, 7), as was the position of the C-19 methyl signal (81.18). The side chain C-26/C-27 was shown to be intact (81.21), and the C-21 signal (80.93) with J = 6.4 Hz and the C-18 signal (80.72) were also observed.
The 13C chemical shift data for compound 2 are given in Table 1 and were compared with those of the starting material and to 4-cholesten-3-one. The proton noise decoupled spectrum was compared to that of 4-cholesten-3-one (3), and the ABCD ring chemical shifts were found to be virtually identical. The HC25 side chain data were essentially the same as that of the first metabolite. Combination of the two structural pieces provided evidence of structure as 25-hydroxy-4-cholesten-3-one.
Results of the UV and IR analyses indicated the characteristic UV absorbance of 242 nm indicative of a conjugated 4-ene-3-one plus the typical IR carbonyl band at 6.06 ,um shifted slightly as a result of a, 1B unsaturation.
(iii) Compound 3. If a C27 steroid contained three hydroxy groups, the molecular weight VOL. 43, 1982 on July 6, 2017 by guest http://aem.asm.org/ Downloaded from IR and UV spectral results have been determined (Table 1) to be virtually the same as for the 6P-hydroxylated metabolite. Combination of the analytical data provided verification for the structure of compound 4 to be 6ac,25-dihydroxy-4-cholesten-3-one.
The structures of the metabolites of HC25 are shown in Fig. 4 . DISCUSSION HC25 is transformed by R. muneratii ATCC 13247 into three products. In each of these products the 3-oxo-4-ene configuration was observed, rather than the 3-ol-5-ene configuration of the starting material. Compound 2, 25-hydroxy-4-cholesten-3-one, was found to be the oxidized and isomerized product with no concomitant hydroxylation. The other two products, compounds 3 and 4, were found to contain hydroxy groups at the 6-carbon position. Compound 3, the 6p3-hydroxylated isomer, was the predominant product of the fermentation when the culture was terminated after 48 h of incubation. This steroid appeared in the product mixture in the presence or absence of the surfactant Triton X-100, as did compound 2. On the contrary, the 6a-hydroxylated product, compound 4, was found only in the absence of Triton X-100. The ratio of 6p-to 6a-hydroxylated product from the Triton X-100-free culture was approximately 7:1.
The role of Triton X-100 in mediating the appearance of compound 4 is not precisely understood at present. Surfactants such as Triton X-100 have been shown to affect the catalytic properties of both microbial (14, 15) and mammalian (4) enzymes. In particular, the production of cholesterol oxidase by microbial cultures has been increased threefold by the inclusion of surfactants in the growth medium (P. S. Masurekar and C. T. Goodhue, U.S. patent 4,093,517, 6 June 1978). It is believed that a similar "surfactant effect" may have been observed with this strain, the net result being an absence of detectable compound 4 when Triton X-100 was included in the growth medium.
The results obtained from the 48-h incubation of HC25 with this strain indicate that at this point in the fermentation little, if any, degradation of the steroids to nonsteroid metabolites had occurred. Although no attempts were made to increase yields, a study of modifications to the fermentation might lead to an overall improvement in various product yields. This microbial reaction system may be of interest, especially for production of useful intermediates needed for subsequent chemical reactions.
